JP Morgan Chase
MNOV icon

JP Morgan Chase’s MediciNova MNOV Stock Holding History

JP Morgan Chase’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28K Buy
20,576
+20,000
+3,472% +$30.3K ﹤0.01% 6426
2025
Q4 		$755 Buy
576
+500
+658% +$690 ﹤0.01% 7047
2025
Q3 		$96 Hold
76
– – ﹤0.01% 7177
2025
Q2 		$100 Sell
76
-8,600
-99% -$12K ﹤0.01% 6838
2025
Q1 		$12.7K Buy
8,676
+7,400
+580% +$13.1K ﹤0.01% 6251
2024
Q4 		$2.68K Sell
1,276
-10,000
-89% -$19.5K ﹤0.01% 6607
2024
Q3 		$23.7K Buy
11,276
+5,900
+110% +$8.73K ﹤0.01% 6197
2024
Q2 		$7.74K Sell
5,376
-28,100
-84% -$39.4K ﹤0.01% 6306
2024
Q1 		$48.5K Sell
33,476
-99,957
-75% -$142K ﹤0.01% 5958
2023
Q4 		$200K Sell
133,433
-1,943
-1% -$3.51K ﹤0.01% 5388
2023
Q3 		$283K Sell
135,376
-32,836
-20% -$76.4K ﹤0.01% 4834
2023
Q2 		$387K Sell
168,212
-8,164
-5% -$18K ﹤0.01% 4652
2023
Q1 		$381K Sell
176,376
-72,969
-29% -$167K ﹤0.01% 4662
2022
Q4 		$511K Sell
249,345
-48,731
-16% -$108K ﹤0.01% 4503
2022
Q3 		$647K Buy
298,076
+2,700
+0.9% +$6.25K ﹤0.01% 4290
2022
Q2 		$747K Sell
295,376
-12,900
-4% -$33.7K ﹤0.01% 4295
2022
Q1 		$823K Buy
308,276
+7,110
+2% +$17.4K ﹤0.01% 4404
2021
Q4 		$807K Buy
301,166
+24,021
+9% +$80.3K ﹤0.01% 4535
2021
Q3 		$1.05M Buy
277,145
+3,572
+1% +$13.6K ﹤0.01% 4269
2021
Q2 		$1.16M Buy
273,573
+18,020
+7% +$77.6K ﹤0.01% 4187
2021
Q1 		$1.29M Buy
255,553
+142,553
+126% +$829K ﹤0.01% 4034
2020
Q4 		$595K Buy
113,000
+71,618
+173% +$410K ﹤0.01% 4273
2020
Q3 		$211K Buy
41,382
+27,212
+192% +$157K ﹤0.01% 4336
2020
Q2 		$77K Sell
14,170
-19,791
-58% -$105K ﹤0.01% 4667
2020
Q1 		$126K Buy
33,961
+20,465
+152% +$107K ﹤0.01% 4450
2019
Q4 		$91K Hold
13,496
– – ﹤0.01% 4935
2019
Q3 		$107K Buy
13,496
+2,113
+19% +$18.8K ﹤0.01% 4878
2019
Q2 		$110K Sell
11,383
-3,718
-25% -$39.2K ﹤0.01% 4894
2019
Q1 		$126K Buy
15,101
+4,844
+47% +$42.2K ﹤0.01% 4814
2018
Q4 		$84K Buy
10,257
+1,025
+11% +$10.2K ﹤0.01% 4907
2018
Q3 		$115K Sell
9,232
-2,594
-22% -$26.1K ﹤0.01% 4895
2018
Q2 		$94K Buy
11,826
+1,942
+20% +$20.1K ﹤0.01% 4857
2018
Q1 		$101K Sell
9,884
-8,172
-45% -$81.4K ﹤0.01% 4582
2017
Q4 		$117K Buy
18,056
+13,180
+270% +$87.4K ﹤0.01% 4608
2017
Q3 		$31K Buy
4,876
+4,800
+6,316% +$25.5K ﹤0.01% 4563
2017
Q2 		$0 Hold
76
– – ﹤0.01% 5114
2017
Q1 		$0 Sell
76
-1,700
-96% -$10.2K ﹤0.01% 5164
2016
Q4 		$11K Buy
1,776
+300
+20% +$2.11K ﹤0.01% 4785
2016
Q3 		$11K Buy
1,476
+1,400
+1,842% +$9.43K ﹤0.01% 4282
2016
Q2 		$1K Hold
76
– – ﹤0.01% 4680
2016
Q1 		$1K Buy
+76
New +$376 ﹤0.01% 4572

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

JP Morgan Chase's MNOV Position: Q1 2026 in Review

JP Morgan Chase increased its MediciNova (MNOV) stake by 3,472% in Q1 2026, buying an estimated $30.3K and bringing the position to 20,576 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #6426.

JP Morgan Chase first reported a position in MNOV in Q1 2016 and has held it in 41 quarters since. The position peaked at $1.29M in Q1 2021. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • JP Morgan Chase held 20,576 shares of MediciNova worth $28K as of Q1 2026.
  • JP Morgan Chase bought 20,000 MediciNova shares in Q1 2026, an estimated $30.3K.
  • MediciNova made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6426 holding.
  • JP Morgan Chase first reported a position in MediciNova in Q1 2016 and has held it in 41 quarters since.
  • JP Morgan Chase's MediciNova position peaked at $1.29M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.